Review

Nature Reviews Neuroscience 4, 873-884 (November 2003) | doi:10.1038/nrn1247

The molecular logic of endocannabinoid signalling

Daniele Piomelli1  About the author

Top

The endocannabinoids are a family of lipid messengers that engage the cell surface receptors that are targeted by Delta9-tetrahydrocannabinol, the active principle in marijuana (Cannabis). They are made on demand through cleavage of membrane precursors and are involved in various short-range signalling processes. In the brain, they combine with CB1 cannabinoid receptors on axon terminals to regulate ion channel activity and neurotransmitter release. Their ability to modulate synaptic efficacy has a wide range of functional consequences and provides unique therapeutic possibilities.

Author affiliations

  1. Department of Pharmacology, University of California, Irvine 92697-4625, USA.
    Email: piomelli@uci.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

NEWS AND VIEWS
Anandamide: a candidate neurotransmitter heads for the big leagues
Nature Neuroscience News and Views (01 Apr 1999)
Neurobiology: Never fear, cannabinoids are here
Nature News and Views (01 Aug 2002)
See all 5 matches for News And Views

RESEARCH
Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels
Nature Letters to Editor (24 Jul 2003)
See all 17 matches for Research

Extra navigation

Subscribe

Subscribe to Nature Reviews Neuroscience

Search PubMed for

Open Innovation Challenges

naturejobs

natureproducts


Advertisement